197 related articles for article (PubMed ID: 30638605)
1. Comparison of the
McDermott S; Kilcoyne A; Wang Y; Scott JA; Halpern EF; Ackman JB
Clin Radiol; 2019 Mar; 74(3):187-195. PubMed ID: 30638605
[TBL] [Abstract][Full Text] [Related]
2. Comparison of
Scott JA; McDermott S; Kilcoyne A; Wang Y; Halpern EF; Ackman JB
Clin Radiol; 2019 Sep; 74(9):692-696. PubMed ID: 31202569
[TBL] [Abstract][Full Text] [Related]
3. Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT.
Chun EJ; Lee HJ; Kang WJ; Kim KG; Goo JM; Park CM; Lee CH
Lung Cancer; 2009 Aug; 65(2):180-6. PubMed ID: 19155090
[TBL] [Abstract][Full Text] [Related]
4. Can dynamic imaging, using
Marin A; Murchison JT; Skwarski KM; Tavares AAS; Fletcher A; Wallace WA; Salapura V; van Beek EJR; Mirsadraee S
Radiol Oncol; 2021 May; 55(3):259-267. PubMed ID: 34051709
[TBL] [Abstract][Full Text] [Related]
5. Using neighborhood gray tone difference matrix texture features on dual time point PET/CT images to differentiate malignant from benign FDG-avid solitary pulmonary nodules.
Chen S; Harmon S; Perk T; Li X; Chen M; Li Y; Jeraj R
Cancer Imaging; 2019 Aug; 19(1):56. PubMed ID: 31420006
[TBL] [Abstract][Full Text] [Related]
6. Can spectral computed tomography imaging improve the differentiation between malignant and benign pulmonary lesions manifesting as solitary pure ground glass, mixed ground glass, and solid nodules?
Chen ML; Li XT; Wei YY; Qi LP; Sun YS
Thorac Cancer; 2019 Feb; 10(2):234-242. PubMed ID: 30582292
[TBL] [Abstract][Full Text] [Related]
7. Detection efficacy of analog [
Chen Z; Long Y; Zhang Y; Zhang B; He Q; Zhang X
Eur Radiol; 2023 Mar; 33(3):2118-2127. PubMed ID: 36322193
[TBL] [Abstract][Full Text] [Related]
8. Limited diagnostic value of Dual-Time-Point (18)F-FDG PET/CT imaging for classifying solitary pulmonary nodules in granuloma-endemic regions both at visual and quantitative analyses.
Chen S; Li X; Chen M; Yin Y; Li N; Li Y
Eur J Radiol; 2016 Oct; 85(10):1744-1749. PubMed ID: 27666611
[TBL] [Abstract][Full Text] [Related]
9. Amide proton transfer-weighted imaging to differentiate malignant from benign pulmonary lesions: Comparison with diffusion-weighted imaging and FDG-PET/CT.
Ohno Y; Kishida Y; Seki S; Yui M; Miyazaki M; Koyama H; Yoshikawa T
J Magn Reson Imaging; 2018 Apr; 47(4):1013-1021. PubMed ID: 28799280
[TBL] [Abstract][Full Text] [Related]
10. The Multicenter Italian Trial Assesses the Performance of FDG-PET /CT Related to Pre-Test Cancer Risk in Patients with Solitary Pulmonary Nodules and Introduces a Segmental Thoracic Diagnostic Strategy.
Spadafora M; Evangelista L; Fiordoro S; Porcaro F; Sicignano M; Mansi L
Curr Radiopharm; 2020; 13(3):243-248. PubMed ID: 32186274
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of resected solitary ground-glass opacities: Comparison between benign and malignant nodules.
Qin Y; Xu Y; Ma D; Tian Z; Huang C; Zhou X; He J; Liu L; Guo C; Wang G; Zhang J; Wang Y; Liu H
Thorac Cancer; 2020 Oct; 11(10):2767-2774. PubMed ID: 32844603
[TBL] [Abstract][Full Text] [Related]
12. Quantitative CT Scanning Analysis of Pure Ground-Glass Opacity Nodules Predicts Further CT Scanning Change.
Bak SH; Lee HY; Kim JH; Um SW; Kwon OJ; Han J; Kim HK; Kim J; Lee KS
Chest; 2016 Jan; 149(1):180-91. PubMed ID: 26313232
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ
AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930
[TBL] [Abstract][Full Text] [Related]
14. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.
Kim SC; Machac J; Krynyckyi BR; Knesaurek K; Krellenstein D; Schultz B; Gribetz A; DePalo L; Teirstein A; Kim CK
Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030
[TBL] [Abstract][Full Text] [Related]
15. Is there a role for FDG PET in the management of lung cancer manifesting predominantly as ground-glass opacity?
Kim TJ; Park CM; Goo JM; Lee KW
AJR Am J Roentgenol; 2012 Jan; 198(1):83-8. PubMed ID: 22194482
[TBL] [Abstract][Full Text] [Related]
16. Characterization of pulmonary lesions with low F-18 FDG uptake using double phase F-18 FDG PET/CT: comparison of visual and quantitative analyses.
Kim IJ; Kim SJ; Kim YS; Lee TH; Jeong YJ
Neoplasma; 2009; 56(1):33-9. PubMed ID: 19152243
[TBL] [Abstract][Full Text] [Related]
17. Respiratory-gated imaging in metabolic evaluation of small solitary pulmonary nodules: 18F-FDG PET/CT and correlation with histology.
Farid K; Poullias X; Alifano M; Regnard JF; Servois V; Caillat-Vigneron N; Petras S
Nucl Med Commun; 2015 Jul; 36(7):722-7. PubMed ID: 25793929
[TBL] [Abstract][Full Text] [Related]
18. Shorter-time dual-phase FDG PET/CT in characterizing solid or ground-glass nodules based on surgical results.
Chiu CF; Lin YY; Hsu WH; Chen CY; Yeh JJ; Kao CH
Clin Imaging; 2012; 36(5):509-14. PubMed ID: 22920354
[TBL] [Abstract][Full Text] [Related]
19. Contribution of nonattenuation-corrected images on FDG-PET/CT in the assessment of solitary pulmonary nodules.
Şahin E; Kara A; Elboğa U
Radiol Med; 2016 Dec; 121(12):944-949. PubMed ID: 27567614
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images.
Nomori H; Watanabe K; Ohtsuka T; Naruke T; Suemasu K; Uno K
Lung Cancer; 2004 Jul; 45(1):19-27. PubMed ID: 15196730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
